{ "cik": 1515673, "cik_padded": "0001515673", "entityName": "Ultragenyx Pharmaceutical Inc.", "fiscal_years": [ { "accn": "0001193125-26-057329", "filed": "2026-02-18", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6000000.0, "cash": 421000000.0, "eps_diluted": -5.83, "free_cash_flow": -472000000.0, "net_income": -575000000.0, "operating_cash_flow": -466000000.0, "operating_income": -535000000.0, "revenue": 673000000.0, "stockholders_equity": -80000000.0, "total_assets": 1532000000.0, "total_liabilities": 1605000000.0 }, "period_end": "2025-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.8543833580980683, "operating_margin": -0.7949479940564637, "revenue_growth_yoy": 0.2017857142857143, "roa_avg2y": -0.37891268533772654, "roa_period_end": -0.3753263707571801, "roe_avg2y": -6.571428571428571 } }, { "accn": "0001193125-26-057329", "filed": "2026-02-18", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 7000000.0, "cash": 174000000.0, "eps_diluted": -6.29, "free_cash_flow": -421000000.0, "net_income": -569000000.0, "operating_cash_flow": -414000000.0, "operating_income": -536000000.0, "revenue": 560000000.0, "stockholders_equity": 255000000.0, "total_assets": 1503000000.0, "total_liabilities": 1241000000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 4.866666666666666, "net_margin": -1.0160714285714285, "operating_margin": -0.9571428571428572, "revenue_growth_yoy": 0.2903225806451613, "roa_avg2y": -0.38009187000858047, "roa_period_end": -0.3785761809713905, "roe_avg2y": -2.147169811320755, "roe_period_end": -2.231372549019608 } }, { "accn": "0001193125-26-057329", "filed": "2026-02-18", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 44000000.0, "cash": 214000000.0, "eps_diluted": -8.25, "free_cash_flow": -519000000.0, "net_income": -607000000.0, "operating_cash_flow": -475000000.0, "operating_income": -569000000.0, "revenue": 434000000.0, "stockholders_equity": 275000000.0, "total_assets": 1491013000.0, "total_liabilities": 1215599000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 4.42036, "net_margin": -1.3986175115207373, "operating_margin": -1.3110599078341014, "revenue_growth_yoy": 0.19450965928951447, "roa_avg2y": -0.3998080657819294, "roa_period_end": -0.4071057730549633, "roe_avg2y": -1.9362041467304625, "roe_period_end": -2.207272727272727 } }, { "accn": "0001193125-26-057329", "filed": "2026-02-18", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 116123000.0, "cash": 132944000.0, "eps_diluted": -10.12, "free_cash_flow": -496588000.0, "net_income": -707421000.0, "operating_cash_flow": -380465000.0, "operating_income": -648919000.0, "revenue": 363329000.0, "stockholders_equity": 352000000.0, "total_assets": 1545444000.0, "total_liabilities": 1192950000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.3890625, "revenue_growth_yoy": 0.033929414978685624, "roa_avg2y": -0.46118491799281647, "roa_period_end": -0.45774612344413645, "roe_avg2y": -1.1100622096549322, "roe_period_end": -2.00971875 } }, { "accn": "0000950170-25-023312", "filed": "2025-02-19", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 73093000.0, "cash": 307584000.0, "eps_diluted": -6.7, "free_cash_flow": -411788000.0, "net_income": -454025000.0, "operating_cash_flow": -338695000.0, "operating_income": -381737000.0, "revenue": 351406000.0, "stockholders_equity": 922561000.0, "total_assets": 1522397000.0, "total_liabilities": 599836000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6501857329759224, "net_margin": -1.2920240405684593, "operating_margin": -1.08631326727489, "revenue_growth_yoy": 0.29655757665203114, "roa_avg2y": -0.2766798539405817, "roa_period_end": -0.29823035647074975, "roe_avg2y": -0.43720653886301747, "roe_period_end": -0.49213547938835484 } }, { "accn": "0000950170-24-017879", "filed": "2024-02-21", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 43905000.0, "cash": 713526000.0, "eps_diluted": -3.07, "free_cash_flow": -176125000.0, "net_income": -186566000.0, "operating_cash_flow": -132220000.0, "operating_income": -330116000.0, "revenue": 271030000.0, "stockholders_equity": 1154375000.0, "total_assets": 1759555000.0, "total_liabilities": 605180000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5242490525175961, "net_margin": -0.6883592222263217, "operating_margin": -1.2180053868575433, "revenue_growth_yoy": 1.6132441136201476, "roa_avg2y": -0.12888615779134807, "roa_period_end": -0.10603021786758583, "roe_avg2y": -0.20636245332908587, "roe_period_end": -0.161616459122902 } }, { "accn": "0001564590-21-005610", "filed": "2023-02-17", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 24832000.0, "cash": 433584000.0, "free_cash_flow": -370215000.0, "net_income": -402727000.0, "operating_cash_flow": -345383000.0, "operating_income": -424173000.0, "revenue": 103714000.0, "stockholders_equity": 653764000.0, "total_assets": 1135496000.0, "total_liabilities": 481732000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7368591724230762, "revenue_growth_yoy": 1.0140596174385863, "roa_avg2y": -0.43419436846582365, "roa_period_end": -0.3546705580644934, "roe_avg2y": -0.6378964608386026, "roe_period_end": -0.6160128119627266 } }, { "accn": "0001564590-21-005610", "filed": "2022-02-15", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4076000.0, "cash": 113432000.0, "free_cash_flow": -294642000.0, "net_income": -197611000.0, "operating_cash_flow": -290566000.0, "operating_income": -371373000.0, "revenue": 51495000.0, "stockholders_equity": 608908000.0, "total_assets": 719558000.0, "total_liabilities": 110650000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.18171874897357237, "revenue_growth_yoy": 18.714777947932618, "roa_avg2y": -0.326545821693763, "roa_period_end": -0.27462831349244954, "roe_avg2y": -0.3982639399735177, "roe_period_end": -0.3245334270530195 } }, { "accn": "0001564590-21-005610", "filed": "2021-02-12", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2793000.0, "cash": 100488000.0, "free_cash_flow": -256636000.0, "net_income": -302139000.0, "operating_cash_flow": -253843000.0, "operating_income": -328942000.0, "revenue": 2612000.0, "stockholders_equity": 383454000.0, "total_assets": 490753000.0, "total_liabilities": 107299000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.27982235157280927, "revenue_growth_yoy": 18.639097744360903, "roa_avg2y": -0.5858932555345804, "roa_period_end": -0.615664091712124, "roe_avg2y": -0.7047565509873716, "roe_period_end": -0.7879406656339483 } }, { "accn": "0001564590-20-004667", "filed": "2020-02-14", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 10188000.0, "cash": 161120000.0, "free_cash_flow": -171163000.0, "net_income": -245874000.0, "operating_cash_flow": -160975000.0, "operating_income": -248007000.0, "revenue": 133000.0, "stockholders_equity": 473974000.0, "total_assets": 540626000.0, "total_liabilities": 66652000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1406237472941554, "roa_period_end": -0.45479499691098835, "roe_period_end": -0.5187499736272454 } } ], "latest_filing": { "accn": "0001193125-26-057329", "filed": "2026-02-18", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001515673.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001515673.json" }, "ticker": "RARE" }